. 2022 Nov 5;11(11):2190. doi: 10.3390/antiox11112190

Table 4.

Serum fasting glucose, insulin resistance and lipid profile of rats in the experimental groups.

	CON	OB	OB + BB	OB + OR
Fasting glucose (mg/dL)	70.50 ± 1.45	83.00 ± 3.54 ^a	73.22 ± 1.36 ^b	74.50 ± 1.93 ^b
Fasting insulin (ng/mL)	0.64 ± 0.09	3.71 ± 1.33 ^a	1.22 ± 0.22 ^b	1.80 ±0.09 ^b
HOMA-IR	0.12 ± 0.01	0.38 ± 0.07 ^a	0.22 ± 0.03 ^b	0.26 ± 0.05 ^a
TG (mmol/L)	0.49 ± 0.03	0.92 ± 0.03 ^a	0.60 ± 0.06 ^b	0.77 ± 0.08 ^a
TC (mmol/L)	1.66 ± 0.10	2.79 ± 0.40 ^a	1.97 ± 0.06 ^b	2.01 ± 0.09 ^b
LDL-C (mmol/L)	0.80 ± 0.04	1.80 ± 0.24 ^a	1.12 ± 0.10 ^b	1.03 ± 0.08 ^b
HDL-C (mmol/L)	0.53 ± 0.02	0.40 ± 0.02 ^a	0.49 ± 0.04	0.66 ± 0.03 ^a,b,c

Data are presented as mean ± SEM, n = 8/group. CON, control; OB, obese; OB + BB, obese + bee bread 0.5 g/kg body weight/day; OB + OR, obese + orlistat 10 mg/kg body weight/day; HOMA-IR, homeostatic model of assessment-insulin resistance; TG, triglyceride; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol. One-way ANOVA, followed by Tukey post-hoc test. ^a p < 0.05 vs. CON group, ^b p < 0.05 vs. OB group, ^c p < 0.05 vs. BB group.